Skip to main content

Lack Of Regulation Stunts Growth Of New York State's Legal CBD And Marijuana Industries

New York State is anxiously awaiting legalization of adult recreational marijuana and regulations for CBD in food and drink.

New York Gov. Andrew Cuomo speaks about the $175.5 billion state budget during a news conference in the Red Room at the state Capitol Sunday, March, 31, 2019, in Albany, N.Y. (AP Photo/Hans Pennink)

ASSOCIATED PRESS

Legalized marijuana won’t be in New York’s annual state budget, Gov. Andrew Cuomo announced Friday. Many expected it to be part of the budget that’s expected to be confirmed tomorrow.

The details will be negotiated before the session closes in June, Cuomo said.

The air was hopeful at the recent Women in Cannabis conference, where policy experts, writers, growers and potential growers cheered at discussions about the April 1 deadline. Experts said they expected some version of the proposal to move forward.

In this Feb. 14, 2019 photo, Colton Welch, a junior at the State University of New York at Morrisville, N.Y., tends hydroponic tomato plants which will provide students with data applicable to cannabis cultivation. The college’s new minor in cannabis studies is among a handful of new university programs aimed at preparing students for careers in marijuana and hemp industries. (AP Photo/Marry Esch)

ASSOCIATED PRESS

Passionate advocates like Mary Pryor, co-founder of Cannaclusive, and Kassandra Frederique, New York State Director of the Drug Policy Alliance, emphasized the need for equity programs in the legislation, ensuring women, POC and people who currently deal marijuana have access to business opportunities.

The CBD market in the U.S. could represent $16 billion by 2025, according to a recent report by Cowen. Still, the prominence of CBD in food and drink, and the crackdown of its use in cafes, bars and restaurants, has confused some consumers. CBD served in food and drink is still illegal, according to the FDA.

Meanwhile, topical CBD products have arrived in two major drugstore chains, CVS and Walgreens, both announced this month. Sephora, Ulta, Neiman Marcus and others already carry CBD products.

Lawmakers need to set standards for CBD products, so the industry can create better products, educate consumers and ease them into buying and using CBD properly.

The U.S. Hemp Authority Seal is a start, but doesn’t hit all the points of entry to the CBD market: from skincare to water to gummies to unregulated, low-quality CBD sold online and in bodegas.

CBD has become popular in Italy and Switzerland, but can have higher THC content, 0.6% in Italy, and 1% in Switzerland, respectively. In the U.S. a CBD product can contain 0.3% THC maximum to be considered legal.

Recently resigned FDA Commissioner Scott Gottlieb said it could be years before adequate regulations are in place for CBD food and drink. For now, Dr. Ned Sharpless, head of the National Cancer Institute, is acting FDA commissioner, which may become permanent.

Conscious marijuana and CBD consumers demand an inclusive industry that educates people on safe, effective dosing.

Conscious marijuana and CBD consumers demand an inclusive industry that educates people on safe, effective dosing. Let’s hope regulation makes its way to the forefront so marijuana and CBD can help heal more people in a natural, safe, non-addictive way.

Original Article Source: https://www.forbes.com/sites/bethkaiserman/2019/03/31/new-york-state-cbd-marijuana/

Comments

Post a Comment

Popular posts from this blog

Could CBD Lead To The Development Of Safer Antipsychotic Medications?

Antipsychotic medications are important for managing a number of different psychiatric ailments, including bipolar disorders, schizophrenia, and even dementia. These drugs can greatly improve the manageability of symptoms that often distort one’s experience of reality. They can also create major mood disruptions and lead to a number of behavioral and emotional difficulties. Antipsychotic and anti-psychosis medications can be life-changing for people with such disorders, enabling them to live more normal and manageable lives without their symptoms taking over. These drugs work by regulating neurotransmitters in the brain so that naturally occurring imbalances and dysfunctions no longer disrupt mental and emotional processes. Often, reaching this outcome is much easier said than done; it can take a lot of time to find courses and combinations of treatments that work. It’s sometimes necessary to make adjustments to find the right balance for the individual and it’s not unusual for outc...
Post a Comment
Read more

Feds Hire Hazmat Firm For Marijuana Eradication Training

An ambitious campaign to decriminalize psychedelics in Washington, D.C., is one step closer to placing their measure on the November ballot with the formal submission of tens of thousands of voter signatures. Organizers have been scrambling for weeks to collect enough signatures from D.C. voters by Monday’s deadline amid historically difficult circumstances: a global pandemic, months of stay-at-home orders and protests over racism and police violence that filled the streets of the nation’s capital. But with the help of innovative signature-gathering techniques and allies flown in from across the country, advocates said they had successfully submitted upwards of 35,000 signatures—more than enough to qualify the initiative. If approved by voters, Initiative 81 would make enforcement of laws against plant- and fungus-based psychedelics among the “lowest law enforcement priorities” for the Metropolitan Police Department. It would not, however, legalize or reduce penalties for the substa...
Post a Comment
Read more

FDA Warns 15 Companies For Illegally Selling CBD Products

The agency also released a consumer update about CBD , the non-psychoactive ingredient in marijuana increasingly used to treat pain and anxiety. Until it learns more about the effectiveness and safety of CBD, the FDA said it cannot generally recognize the ingredient as safe or approve products that contain it. “We remain concerned that some people wrongly think that the myriad of CBD products on the market, many of which are illegal, have been evaluated by the FDA and determined to be safe, or that trying CBD ‘can’t hurt,‘” FDA Principal Deputy Commissioner Amy Abernethy said. The FDA sent letters to the following 15 companies for selling CBD products that violate the Food, Drug and Cosmetic Act, for marketing the products to treat illnesses or for therapeutic use, claiming it’s a dietary supplement or adding it to food for humans and animals. -Red Pill Medical Inc. of Phoenix, Arizona -Pink Collections Inc. of Beverly Hills, California -Healthy Hemp Strategies LLC (does ...
Post a Comment
Read more